[go: up one dir, main page]

CN101823974A - Preparation method by adopting (R)-(-)-glycerinchlorohydrin as chirality starting material to synthetize L-carnitine - Google Patents

Preparation method by adopting (R)-(-)-glycerinchlorohydrin as chirality starting material to synthetize L-carnitine Download PDF

Info

Publication number
CN101823974A
CN101823974A CN 201010177701 CN201010177701A CN101823974A CN 101823974 A CN101823974 A CN 101823974A CN 201010177701 CN201010177701 CN 201010177701 CN 201010177701 A CN201010177701 A CN 201010177701A CN 101823974 A CN101823974 A CN 101823974A
Authority
CN
China
Prior art keywords
carnitine
starting material
chloroglycerol
preparation
chiral starting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 201010177701
Other languages
Chinese (zh)
Inventor
杨云旭
王伟力
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Science and Technology Beijing USTB
Original Assignee
University of Science and Technology Beijing USTB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Science and Technology Beijing USTB filed Critical University of Science and Technology Beijing USTB
Priority to CN 201010177701 priority Critical patent/CN101823974A/en
Publication of CN101823974A publication Critical patent/CN101823974A/en
Pending legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

本发明提出一种以(R)-(-)-氯代甘油为手性起始原料合成L-肉碱的制备方法,属于药物化学领域。本发明包括步骤:以手性拆分外消旋环氧氯丙烷制取L-肉碱时的副产物(R)-(-)-氯代甘油为手性起始原料,先使(R)-(-)-氯代甘油和亚硫酰氯反应,生成环状亚磺酸酯中间体;此环状中间体和KCN或NaCN发生开环反应,生成氯代丁基腈;氯代丁基腈在三甲胺溶液中反应,制得氰盐;最终氰盐在酸性溶液里水解,并经离子交换脱去氯离子,制得最终产物L-肉碱。本发明的优点在于使用廉价易得的手性拆分外消旋环氧氯丙烷制取L-肉碱时的副产物(R)-(-)-氯代甘油为手性起始原料,使得L-肉碱的制备所用原料易得、工艺路线短、反应操作简便易行。The invention proposes a preparation method for synthesizing L-carnitine by using (R)-(-)-chloroglycerol as a chiral starting material, which belongs to the field of medicinal chemistry. The invention comprises the steps of: taking the by-product (R)-(-)-chloroglycerol as the chiral starting material when preparing L-carnitine by chiral resolution of racemic epichlorohydrin, first making (R) -(-)-Chloroglycerin reacts with thionyl chloride to generate a cyclic sulfinate intermediate; this cyclic intermediate reacts with KCN or NaCN to generate chlorobutyl nitrile; chlorobutyl nitrile Reaction in trimethylamine solution to produce cyanide salt; the final cyanide salt is hydrolyzed in acidic solution, and the chloride ion is removed by ion exchange to obtain the final product L-carnitine. The advantage of the present invention is that the by-product (R)-(-)-chloroglycerol when using cheap and easy-to-get chiral resolution racemic epichlorohydrin to prepare L-carnitine is the chiral starting material, so that The raw materials used in the preparation of L-carnitine are easily available, the process route is short, and the reaction operation is simple and easy.

Description

一种以(R)-(-)-氯代甘油为手性起始原料合成L-肉碱的制备方法 A preparation method for synthesizing L-carnitine with (R)-(-)-chloroglycerol as chiral starting material

技术领域technical field

本发明属于药物化学领域,涉及一种以(R)-(-)-氯代甘油为手性起始原料合成L-肉碱的制备方法,特别涉及一种以手性拆分外消旋环氧氯丙烷制取L-肉碱时的副产物(R)-(-)-氯代甘油为手性起始原料合成L-肉碱的方法。The invention belongs to the field of medicinal chemistry, and relates to a preparation method for synthesizing L-carnitine by using (R)-(-)-chloroglycerol as a chiral starting material, in particular to a method for splitting a racemic ring by chirality A method for synthesizing L-carnitine by using the by-product (R)-(-)-chloroglycerin when L-carnitine is prepared from oxychloropropane as a chiral starting material.

背景技术Background technique

L-肉碱又称左旋肉碱或维生素BT,化学名称为(R)-(-)-3-羟基-4-三甲铵基丁酸,化学结构式为:L-carnitine is also called L-carnitine or vitamin B T , its chemical name is (R)-(-)-3-hydroxy-4-trimethylammonium butyric acid, and its chemical structure is:

L-肉碱是一种具有广泛生理活性和广阔生理学前景的化合物。自80年代在美国上市,被广泛应用于临床治疗心力衰竭、增强肌肉耐力及迅速恢复等。由于仅R-构型的肉碱有正常的生理作用,而其对映体S-构型不但无作用,在有些代谢过程中还是R-构型肉碱的竞争性抑制剂,因此多年来,众多研究者报道了L-肉碱的合成工艺(例如:①美国专利US 5473104,1995年。②Robert,V.;Jean-Claude,P.;et.al.,Helv.Chim.Acta,1987,70,2058)。L-carnitine is a compound with extensive physiological activities and broad physiological prospects. Since it was launched in the United States in the 1980s, it has been widely used in clinical treatment of heart failure, enhancement of muscle endurance and rapid recovery. Because only R-configuration carnitine has normal physiological effects, and its enantiomer S-configuration not only has no effect, but is also a competitive inhibitor of R-configuration carnitine in some metabolic processes, so for many years, Numerous researchers have reported the synthetic technique of L-carnitine (for example: 1. U.S. Patent US 5473104, 1995. 2. Robert, V.; Jean-Claude, P.; et.al., Helv.Chim.Acta, 1987,70 , 2058).

自1997年E.N.Jacobsen报道了以手性SalenCo(III)对外消旋环氧化合物的水解动力学拆分后(Tokunaga,M.;Larrow,J.F.;Kakiuchi,F.;Jacobsen,E.N.,Science,1997,277,936-938.),外消旋环氧氯丙烷己可大规模地拆分制备手性“砌块”物质(S)-(+)-环氧氯丙烷和(R)-(-)-氯代甘油。众多的L-肉碱生产企业在L-生产工艺上,较多的是采用了直接使用(S)-(+)-环氧氯丙烷为手性起始原料制L-肉碱(例如,顾松林,芮丽琴,周斌等,合成化学,2004,12,383-384.)。Since E.N.Jacobsen reported in 1997 (Tokunaga, M.; Larrow, J.F.; Kakiuchi, F.; Jacobsen, E.N., Science, 1997, 277, 936-938.), racemic epichlorohydrin can be resolved on a large scale to prepare chiral "block" substances (S)-(+)-epichlorohydrin and (R)-(-) - Chloroglycerin. Numerous L-carnitine production enterprises mostly adopt (S)-(+)-epichlorohydrin to be the chiral starting raw material system L-carnitine (for example, Gu Song Lin, Rui Liqin, Zhou Bin, etc., Synthetic Chemistry, 2004, 12, 383-384.).

Figure GSA00000122177400021
Figure GSA00000122177400021

从上述可知,手性拆分外消旋环氧氯丙烷制取L-肉碱时的副产物(R)-(-)-氯代甘油也是一种廉价易得的手性“砌块”物质。利用此手性“砌块”物质直接制备L-肉碱,具有非常现实工业化意义。From the above, it can be seen that the by-product (R)-(-)-chloroglycerin produced by chiral resolution of racemic epichlorohydrin to prepare L-carnitine is also a cheap and easy-to-obtain chiral "building block" substance . Utilizing this chiral "block" substance to directly prepare L-carnitine has very practical industrial significance.

发明内容Contents of the invention

本发明的目的,在于提供一种以(R)-(-)-氯代甘油为手性起始原料合成L-肉碱的制备方法,该方法是以手性拆分外消旋环氧氯丙烷制取L-肉碱时的副产物(R)-(-)-氯代甘油为手性起始原料,直接高效转化制备L-肉碱。本发明提出的以(R)-(-)-氯代甘油手性起始原料制备L-肉碱的方法路线如下:The purpose of the present invention is to provide a kind of preparation method using (R)-(-)-chloroglycerin as chiral starting material to synthesize L-carnitine, the method is to split racemic epoxy chloride by chirality The by-product (R)-(-)-chloroglycerol used in the production of L-carnitine from propane is used as a chiral starting material, which can be directly and efficiently converted to produce L-carnitine. The method route for preparing L-carnitine with (R)-(-)-chloroglycerol chiral starting material proposed by the present invention is as follows:

Figure GSA00000122177400031
Figure GSA00000122177400031

本发明的合成方法,具体包括如下步骤:The synthetic method of the present invention specifically comprises the steps:

(1)将(R)-(-)-氯代甘油在低温下和亚硫酰氯进行环化反应,经蒸馏除去低沸点物质后,得到环状亚磺酸酯中间体,此中间体不必纯化精制,可直接用于下步合成反应。(1) Carry out cyclization reaction of (R)-(-)-chloroglycerol with thionyl chloride at low temperature, and remove low boiling point substances by distillation to obtain a cyclic sulfinate intermediate, which does not need to be purified Refined, it can be directly used in the next step of synthesis reaction.

(2)在温度范围为10℃~110℃内,将步骤(1)中制得的环状亚磺酸酯中间体加入极性溶剂中,与氰化无机盐反应开环,得到环状亚磺酸酯开环物后并将其经酸水解后,制得氯代丁基腈中间体。(2) In the temperature range of 10°C to 110°C, add the cyclic sulfinate intermediate prepared in step (1) into a polar solvent, react with cyanide inorganic salt to open the ring, and obtain the cyclic sulfinate intermediate After sulfonate ring opening and acid hydrolysis, the chlorobutyl nitrile intermediate is obtained.

(3)将步骤(2)中制得的氯代丁基腈中间体和三甲胺溶液,在0℃~100℃温度下反应,待反应完成后,减压蒸除溶剂,并使用重结晶溶剂进行重结晶,制得氰盐中间体。(3) React the chlorobutyl nitrile intermediate and trimethylamine solution prepared in step (2) at a temperature of 0°C to 100°C. After the reaction is completed, the solvent is evaporated under reduced pressure, and the recrystallization solvent is used Recrystallization was carried out to obtain a cyanide salt intermediate.

(4)将步骤(3)制得的氰盐中间体,先在酸性条件下水解,再经离子交换脱氯,经重结晶,精制得到L-肉碱。(4) The cyanide salt intermediate obtained in step (3) is first hydrolyzed under acidic conditions, then dechlorinated by ion exchange, recrystallized, and refined to obtain L-carnitine.

所述步骤(1)中的低温度范围为-70℃~0℃,所述(R)-(-)-氯代甘油是手性拆分外消旋环氧氯丙烷制取L-肉碱时的副产物,所得的环状亚磺酸酯中间体可不经进一步纯化处理,直接用于下步反应,其收率达到100%。The low temperature range in the step (1) is -70°C to 0°C, and the (R)-(-)-chloroglycerin is obtained by chiral resolution of racemic epichlorohydrin to prepare L-carnitine When the by-product, the resulting cyclic sulfinate intermediate can be directly used in the next reaction without further purification, and its yield reaches 100%.

所述步骤(2)中,所述极性溶剂是甲醇、乙醇、乙腈、四氢呋喃、N,N-二甲基甲酰胺、二甲基亚砜、水中的任一种溶剂或上述溶剂的混合溶液,所述氰化无机盐为KCN或NaCN,In the step (2), the polar solvent is methanol, ethanol, acetonitrile, tetrahydrofuran, N, N-dimethylformamide, dimethyl sulfoxide, any solvent in water or a mixed solution of the above solvents , the cyanide inorganic salt is KCN or NaCN,

所述步骤(2)中,所得到的氯代丁基腈中间体的收率达到85%。In the step (2), the yield of the obtained chlorobutyl nitrile intermediate reaches 85%.

所述步骤(2)中,所述水解所用稀酸是稀盐酸或稀硫酸。In the step (2), the dilute acid used for the hydrolysis is dilute hydrochloric acid or dilute sulfuric acid.

所述步骤(3)中,所述重结晶溶剂为水、甲醇、乙醇、乙腈或四氢呋喃,所述制得的氰盐中间体收率为80%。In the step (3), the recrystallization solvent is water, methanol, ethanol, acetonitrile or tetrahydrofuran, and the yield of the prepared cyanide salt intermediate is 80%.

所述步骤(3)中,所述重结晶溶剂为甲醇或水。In the step (3), the recrystallization solvent is methanol or water.

所述步骤(4)中,氰盐中间体水解所用酸为盐酸或硫酸溶剂。In the step (4), the acid used for the hydrolysis of the cyanide salt intermediate is hydrochloric acid or sulfuric acid solvent.

本发明的优点在于:使用廉价易得的手性拆分外消旋环氧氯丙烷制取L-肉碱时的副产物(R)-(-)-氯代甘油为手性起始原料,进行转化合成了L-肉碱。使得L-肉碱的制备所用原料易得、工艺路线短、反应操作简便易行。The present invention has the advantages that: the by-product (R)-(-)-chloroglycerol when L-carnitine is prepared by using cheap and easy-to-obtain chiral resolution racemic epichlorohydrin as the chiral starting material, The transformation is carried out to synthesize L-carnitine. The raw materials used in the preparation of L-carnitine are easy to obtain, the process route is short, and the reaction operation is simple and easy.

具体实施方式Detailed ways

实施例1Example 1

(1)将19.19g(0.174mol)(R)-(-)-氯代甘油、50ml二氯甲烷投入250ml三颈瓶中,冰浴条件下,缓慢滴加22.74g(0.191oml)二氯亚砜。反应1h,加入40ml水,有机层用饱和食盐水洗两次,水层用乙酸乙酯洗两次,合并有机层,无水硫酸钠干燥。过滤,滤液减压浓缩,得27.23g无色液体。即环状亚磺酸酯中间体,不经纯化,直接用于下步反应,收率100%。(1) Put 19.19g (0.174mol) (R)-(-)-chloroglycerol and 50ml dichloromethane into a 250ml three-necked bottle, and slowly add 22.74g (0.191oml) dichloromethane dropwise under ice bath conditions sulfone. After reacting for 1 h, 40 ml of water was added, the organic layer was washed twice with saturated brine, the aqueous layer was washed twice with ethyl acetate, the organic layers were combined, and dried over anhydrous sodium sulfate. After filtration, the filtrate was concentrated under reduced pressure to obtain 27.23 g of a colorless liquid. That is, the cyclic sulfinate intermediate was directly used in the next reaction without purification, and the yield was 100%.

(2)投10g(0.064mol)环状亚磺酸酯、30ml甲醇到100ml三颈瓶中,室温条件下,加入5.21g(0.08mol)KCN,搅拌10min,然后升至50℃,剧烈搅拌12h后。减压浓缩,加入15ml乙酸乙酯,缓慢滴加20%H2SO4溶液。搅拌5h后,加入稀NaCO3溶液洗涤两次,水洗两次,饱和食盐水洗涤一次,水层用乙酸乙酯洗,合并有机层,加入无水硫酸钠干燥。减压蒸馏收集89-90℃/<1mmHg馏分,得6.51g无色液体,即氯代丁基腈中间体,其收率为85%。[α]D 25=+6.90(c 3.0,CHCl3);IR(KBr,liqiud film):3431(bs),2960(m),2934(m),2258(m),1415(s),1307(m),1088(s),1057(s),860(m),755(m)cm-11H NMR(400M,CDCl3),δppm:3.21(bs,1H,OH),2.72-2.75(t,2H,-CH2-),3.65-3.67(d,2H,-CH2-),4.16-4.22(br,1H,-CH2CH(OH)CH2-).(2) Throw 10g (0.064mol) cyclic sulfinate and 30ml methanol into a 100ml three-neck flask, add 5.21g (0.08mol) KCN at room temperature, stir for 10min, then rise to 50°C, and stir vigorously for 12h back. Concentrate under reduced pressure, add 15ml of ethyl acetate, and slowly add 20% H 2 SO 4 solution dropwise. After stirring for 5 h, dilute NaCO 3 solution was added to wash twice, water was washed twice, saturated brine was washed once, the aqueous layer was washed with ethyl acetate, the organic layers were combined, and anhydrous sodium sulfate was added to dry. The 89-90° C./<1 mmHg fraction was collected by vacuum distillation to obtain 6.51 g of a colorless liquid, namely the chlorobutyl nitrile intermediate, with a yield of 85%. [α] D 25 =+6.90 (c 3.0, CHCl 3 ); IR (KBr, liquor film): 3431(bs), 2960(m), 2934(m), 2258(m), 1415(s), 1307 (m), 1088(s), 1057(s), 860(m), 755(m)cm -1 ; 1 H NMR (400M, CDCl 3 ), δppm: 3.21(bs, 1H, OH), 2.72- 2.75 (t, 2H, -CH 2 -), 3.65-3.67 (d, 2H, -CH 2 -), 4.16-4.22 (br, 1H, -CH 2 CH(OH)CH 2 -).

(3)19.2g(0.16mol)氯代丁基腈、57.4g(0.34mol)33%的三甲胺水溶液混合均匀于三口瓶中40℃下反应5h,停止反应,减压蒸除溶剂,将所得粗品用甲醇重结晶,得22.85g白色晶体,即氰盐。收率80%。mp220-222℃(dec)。[α]D 20=-26.3(c 1.0,H2O);IR(KBr,liqiud film):v 3260(s),3197(s),3018(m),2979(m),2906(m),2242(m),1477(s),1409(m),1367(m),1230(m),1091(s),965(s),933(s),688(s)cm-11H NMR(400M,D2O),δppm:4.63(m,1H,-CH2CH(OH)CH2-),3.47(dd,2H,-CH2-),3.20(s,9H,-(CH3)3),2.75(dd,2H,-CH2-).(3) 19.2g (0.16mol) of chlorobutyl nitrile, 57.4g (0.34mol) of 33% trimethylamine aqueous solution were mixed uniformly and reacted for 5h at 40°C in a three-necked flask, the reaction was stopped, the solvent was evaporated under reduced pressure, and the obtained The crude product was recrystallized from methanol to obtain 22.85 g of white crystals, namely cyanide salt. Yield 80%. mp220-222°C (dec). [α] D 20 =-26.3 (c 1.0, H 2 O); IR (KBr, liquor film): v 3260(s), 3197(s), 3018(m), 2979(m), 2906(m) , 2242(m), 1477(s), 1409(m), 1367(m), 1230(m), 1091(s), 965(s), 933(s), 688(s) cm -1 ; 1 H NMR (400M, D 2 O), δppm: 4.63 (m, 1H, -CH 2 CH(OH)CH 2 -), 3.47 (dd, 2H, -CH 2 -), 3.20 (s, 9H, -( CH 3 ) 3 ), 2.75 (dd, 2H, -CH 2 -).

(4)将上述3步制得的氰盐20g(0.11mol)、45mL浓盐酸,加入到三口瓶中,升温至回流,4个小时后,停止反应,冷冻,抽滤。滤液用氢氧化钠溶液中和至pH=2.2,再减压蒸除水。加入35ml乙醇,加热回流之后抽滤,滤液浓缩。向浓缩所得固体物中加入130ml去离子水,全溶后,通过强碱性阴离子交换树脂除去氯离子。流出液体减压浓缩至干,加入25ml乙醇重结晶,得到白色针状晶体15g,即L-肉碱。mp 194℃;[α]D 20=30.9(c 10,H2O);IR(KBr,liqiud film):v 3264(s),2997(s),2930(s),2873(s),1725(s),1487(m),1413(m),1185(s),1096(m),935(m),878(m),602(m)cm-11H NMR(400M,D2O),δppm,4.66(m,1H,-CH2CH(OH)CH2-),3.52-3.47(dd,2H,-CH2-),3.24(s,9H,-(CH3)3),2.67-2.63(dd,2H,-CH2-).(4) Add 20 g (0.11 mol) of cyanide salt and 45 mL of concentrated hydrochloric acid prepared in the above three steps into a three-neck flask, heat up to reflux, stop the reaction after 4 hours, freeze, and suction filter. The filtrate was neutralized with sodium hydroxide solution to pH=2.2, and the water was distilled off under reduced pressure. Add 35ml of ethanol, heat to reflux and then filter with suction, and the filtrate is concentrated. Add 130ml of deionized water to the solid obtained by concentrating, after fully dissolving, remove chloride ions by strongly basic anion exchange resin. The effluent liquid was concentrated to dryness under reduced pressure, and 25 ml of ethanol was added for recrystallization to obtain 15 g of white needle-like crystals, that is, L-carnitine. mp 194°C; [α] D 20 =30.9 (c 10, H 2 O); IR (KBr, liquor film): v 3264(s), 2997(s), 2930(s), 2873(s), 1725 (s), 1487(m), 1413(m), 1185(s), 1096(m), 935(m), 878(m), 602(m)cm -1 ; 1 H NMR (400M, D 2 O), δppm, 4.66 (m, 1H, -CH 2 CH(OH)CH 2 -), 3.52-3.47 (dd, 2H, -CH 2 -), 3.24 (s, 9H, -(CH 3 ) 3 ) , 2.67-2.63 (dd, 2H, -CH 2 -).

实施例2Example 2

(1)将38.38g(R)-(-)-氯代甘油、100ml二氯甲烷投入500ml三颈瓶中,冰浴条件下,缓慢滴加45.5g二氯亚砜。反应1h,加入80ml水,有机层用饱和食盐水洗两次,水层用乙酸乙酯洗两次,合并有机层,无水硫酸钠干燥。过滤,滤液减压浓缩,得54.5g无色液体。即环状亚磺酸酯中间体,不经纯化,直接用于下步反应,收率100%。(1) Put 38.38g of (R)-(-)-chloroglycerin and 100ml of dichloromethane into a 500ml three-neck flask, and slowly add 45.5g of thionyl chloride dropwise under ice-bath conditions. After reacting for 1 h, 80 ml of water was added, the organic layer was washed twice with saturated brine, the aqueous layer was washed twice with ethyl acetate, the organic layers were combined, and dried over anhydrous sodium sulfate. After filtration, the filtrate was concentrated under reduced pressure to obtain 54.5 g of a colorless liquid. That is, the cyclic sulfinate intermediate was directly used in the next reaction without purification, and the yield was 100%.

(2)投20g环状亚磺酸酯、60ml乙醇到250ml三颈瓶中,室温条件下,加入10.42g KCN,搅拌1Omin,然后升至60℃,剧烈搅拌12h后。减压浓缩,加入30ml乙酸乙酯,缓慢滴加20%HCl溶液。搅拌5h后,加入稀NaCO3溶液洗涤两次,水洗两次,饱和食盐水洗涤一次,水层用乙酸乙酯洗,合并有机层,加入无水硫酸钠干燥。减压蒸馏收集89-90℃/<1mmHg馏分,得13g无色液体,即氯代丁基腈中间体,其收率为85%。(2) Throw 20g of cyclic sulfinate and 60ml of ethanol into a 250ml three-neck flask, add 10.42g of KCN at room temperature, stir for 10min, then rise to 60°C, and stir vigorously for 12h. Concentrate under reduced pressure, add 30ml of ethyl acetate, and slowly add 20% HCl solution dropwise. After stirring for 5 h, dilute NaCO 3 solution was added to wash twice, water was washed twice, saturated brine was washed once, the aqueous layer was washed with ethyl acetate, the organic layers were combined, and anhydrous sodium sulfate was added to dry. The 89-90°C/<1mmHg fraction was collected by distillation under reduced pressure to obtain 13 g of colorless liquid, namely the chlorobutyl nitrile intermediate, with a yield of 85%.

(3)将38.4g氯代丁基腈、114.8g 33%的三甲胺水溶液混合均匀于三口瓶中45℃下反应4.5h,停止反应,减压蒸除溶剂,将所得粗品用乙醇重结晶,得45.7g白色晶体,即氰盐。收率80%。(3) 38.4g of chlorobutyl nitrile, 114.8g of 33% trimethylamine aqueous solution were mixed and reacted at 45°C in a three-necked flask for 4.5h, the reaction was stopped, the solvent was evaporated under reduced pressure, and the obtained crude product was recrystallized with ethanol, Obtained 45.7g of white crystals, namely cyanide salt. Yield 80%.

(4)将上述3步制得的氰盐40g、50mL浓硫酸,加入到三口瓶中,升温至回流,4.5个小时后,停止反应,冷冻,抽滤。滤液用氢氧化钠溶液中和至pH=2.0,再减压蒸除水。加入70ml乙醇,加热回流之后抽滤,滤液浓缩。向浓缩所得固体物中加入250ml去离子水,全溶后,通过强碱性阴离子交换树脂除去氯离子。流出液体减压浓缩至干,加入50ml乙醇重结晶,得到白色针状晶体30g,即L-肉碱。(4) Add 40 g of the cyanide salt and 50 mL of concentrated sulfuric acid obtained in the above three steps into a three-necked flask, heat up to reflux, stop the reaction after 4.5 hours, freeze, and suction filter. The filtrate was neutralized with sodium hydroxide solution to pH = 2.0, and water was distilled off under reduced pressure. Add 70ml of ethanol, heat to reflux and then filter with suction, and the filtrate is concentrated. Add 250ml of deionized water to the solid obtained by concentration, and after the solution is completely dissolved, chloride ions are removed by a strongly basic anion exchange resin. The effluent liquid was concentrated to dryness under reduced pressure, and 50 ml of ethanol was added for recrystallization to obtain 30 g of white needle-like crystals, that is, L-carnitine.

实施例3Example 3

(1)将28.79g(R)-(-)-氯代甘油、75ml二氯甲烷投入500ml三颈瓶中,冰浴条件下,缓慢滴加34.11g二氯亚砜。反应1h,加入60ml水,有机层用饱和食盐水洗两次,水层用乙酸乙酯洗两次,合并有机层,无水硫酸钠干燥。过滤,滤液减压浓缩,得41g无色液体。即环状亚磺酸酯中间体,不经纯化,直接用于下步反应,收率100%。(1) Put 28.79g of (R)-(-)-chloroglycerol and 75ml of dichloromethane into a 500ml three-neck flask, and slowly add 34.11g of thionyl chloride dropwise under ice-bath conditions. After reacting for 1 h, 60 ml of water was added, the organic layer was washed twice with saturated brine, the aqueous layer was washed twice with ethyl acetate, the organic layers were combined, and dried over anhydrous sodium sulfate. After filtration, the filtrate was concentrated under reduced pressure to obtain 41 g of a colorless liquid. That is, the cyclic sulfinate intermediate was directly used in the next reaction without purification, and the yield was 100%.

(2)投15g环状亚磺酸酯、45ml甲醇到250ml三颈瓶中,室温条件下,加入7.82gKCN,搅拌7min,然后升至55℃,剧烈搅拌12h后。减压浓缩,加入23ml乙酸乙酯,缓慢滴加20%H2SO4溶液。搅拌5h后,加入稀NaCO3溶液洗涤两次,水洗两次,饱和食盐水洗涤一次,水层用乙酸乙酯洗,合并有机层,加入无水硫酸钠干燥。减压蒸馏收集89-90℃/<1mmHg馏分,得9.78g无色液体,即氯代丁基腈中间体,其收率为85%。(2) Throw 15g of cyclic sulfinate and 45ml of methanol into a 250ml three-necked flask, add 7.82g of KCN at room temperature, stir for 7min, then rise to 55°C, and stir vigorously for 12h. Concentrate under reduced pressure, add 23ml of ethyl acetate, and slowly add 20% H 2 SO 4 solution dropwise. After stirring for 5 h, dilute NaCO 3 solution was added to wash twice, water was washed twice, saturated brine was washed once, the aqueous layer was washed with ethyl acetate, the organic layers were combined, and anhydrous sodium sulfate was added to dry. The 89-90° C./<1 mmHg fraction was collected by vacuum distillation to obtain 9.78 g of colorless liquid, namely the chlorobutyl nitrile intermediate, with a yield of 85%.

(3)将28.8g氯代丁基腈、86.1g 33%的三甲胺水溶液混合均匀于三口瓶中40℃下反应5h,停止反应,减压蒸除溶剂,将所得粗品用乙腈重结晶,得34.28g白色晶体,即氰盐。收率80%。(3) Mix 28.8g of chlorobutyl nitrile and 86.1g of 33% trimethylamine aqueous solution to react in a three-necked flask at 40°C for 5h, stop the reaction, evaporate the solvent under reduced pressure, and recrystallize the gained crude product with acetonitrile to obtain 34.28g white crystals, namely cyanide salt. Yield 80%.

(4)将上述步骤(3)制得的氰盐30g、67.5mL浓硫酸,加入到三口瓶中,升温至回流,4个小时后,停止反应,冷冻,抽滤。滤液用氢氧化钠溶液中和至pH=2.2,再减压蒸除水。加入52.5ml乙醇,加热回流之后抽滤,滤液浓缩。向浓缩所得固体物中加入190ml去离子水,全溶后,通过强碱性阴离子交换树脂除去氯离子。流出液体减压浓缩至干,加入37.5ml乙醇重结晶,得到白色针状晶体22.5g,即L-肉碱。(4) Add 30 g of the cyanide salt and 67.5 mL of concentrated sulfuric acid prepared in the above step (3) into a three-necked flask, heat up to reflux, stop the reaction after 4 hours, freeze, and suction filter. The filtrate was neutralized with sodium hydroxide solution to pH=2.2, and the water was distilled off under reduced pressure. Add 52.5ml of ethanol, heat to reflux and then filter with suction, and the filtrate is concentrated. Add 190ml of deionized water to the solid obtained by concentration, after complete dissolution, remove chloride ions by strongly basic anion exchange resin. The effluent liquid was concentrated to dryness under reduced pressure, and 37.5 ml of ethanol was added for recrystallization to obtain 22.5 g of white needle crystals, namely L-carnitine.

Claims (7)

1.一种以(R)-(-)-氯代甘油为手性起始原料合成L-肉碱的制备方法,其特征在于,L-肉碱的合成步骤为:1. a kind of preparation method taking (R)-(-)-chloroglycerol as chiral starting material synthetic L-carnitine, it is characterized in that, the synthetic steps of L-carnitine are: (1)将(R)-(-)-氯代甘油在低温下和亚硫酰氯进行环化反应,经蒸馏除去低沸点物质后,得到环状亚磺酸酯中间体,此中间体不必纯化精制,可直接用于下步合成反应;(1) Carry out cyclization reaction of (R)-(-)-chloroglycerol with thionyl chloride at low temperature, and remove low boiling point substances by distillation to obtain a cyclic sulfinate intermediate, which does not need to be purified Refined, it can be directly used in the next step of synthesis reaction; (2)在温度范围为10℃~110℃内,将步骤(1)中制得的环状亚磺酸酯中间体加入极性溶剂中,与氰化无机盐反应开环,得到环状亚磺酸酯开环物后并将其经酸水解后,制得氯代丁基腈中间体;(2) In the temperature range of 10°C to 110°C, add the cyclic sulfinate intermediate prepared in step (1) into a polar solvent, react with cyanide inorganic salt to open the ring, and obtain the cyclic sulfinate intermediate After the ring-opening of the sulfonic acid ester and its acid hydrolysis, the chlorobutyl nitrile intermediate is obtained; (3)将步骤(2)中制得的氯代丁基腈中间体和三甲胺溶液,在0℃~100℃温度下反应,待反应完成后,减压蒸除溶剂,并使用重结晶溶剂进行重结晶,制得氰盐中间体;(3) React the chlorobutyl nitrile intermediate and trimethylamine solution prepared in step (2) at a temperature of 0°C to 100°C. After the reaction is completed, the solvent is evaporated under reduced pressure, and the recrystallization solvent is used Carry out recrystallization, make cyanide salt intermediate; (4)将步骤(3)制得的氰盐中间体,先在酸性条件下水解,再经离子交换脱氯,经重结晶,精制得到L-肉碱。(4) The cyanide salt intermediate obtained in step (3) is first hydrolyzed under acidic conditions, then dechlorinated by ion exchange, recrystallized, and refined to obtain L-carnitine. 2.根据权利要求1所述的以(R)-(-)-氯代甘油为手性起始原料合成L-肉碱的制备方法,其特征在于,所述步骤(1)中的低温度范围为-70℃~0℃,所述(R)-(-)-氯代甘油是手性拆分外消旋环氧氯丙烷制取L-肉碱时的副产物,所得的环状亚磺酸酯中间体可不经进一步纯化处理,直接用于下步反应,其收率达到100%。2. take (R)-(-)-chloroglycerol according to claim 1 as the preparation method of chiral starting material synthetic L-carnitine, it is characterized in that, the low temperature in described step (1) The range is from -70°C to 0°C. The (R)-(-)-chloroglycerin is a by-product of chiral resolution of racemic epichlorohydrin to prepare L-carnitine. The obtained cyclic sub The sulfonate intermediate can be directly used in the next reaction without further purification, and the yield reaches 100%. 3.根据权利要求1所述的以(R)-(-)-氯代甘油为手性起始原料合成L-肉碱的制备方法,其特征在于,所述步骤(2)中,所述极性溶剂是甲醇、乙醇、乙腈、四氢呋喃、N,N-二甲基甲酰胺、二甲基亚砜、水中的任一种溶剂或上述溶剂的混合溶液;所述氰化无机盐为KCN或NaCN。3. take (R)-(-)-chloroglycerol according to claim 1 as the preparation method of chiral starting material synthetic L-carnitine, it is characterized in that, in described step (2), described The polar solvent is methanol, ethanol, acetonitrile, tetrahydrofuran, N,N-dimethylformamide, dimethyl sulfoxide, any solvent in water or a mixed solution of the above solvents; the cyanide inorganic salt is KCN or NaCN. 4.根据权利要求1所述的以(R)-(-)-氯代甘油为手性起始原料合成L-肉碱的制备方法,其特征在于,所述步骤(2)中,所述水解所用稀酸是稀盐酸或稀硫酸,所得到的氯代丁基腈中间体的收率达到85%。4. take (R)-(-)-chloroglycerol according to claim 1 as the preparation method of chiral starting material synthetic L-carnitine, it is characterized in that, in described step (2), described The dilute acid used for hydrolysis is dilute hydrochloric acid or dilute sulfuric acid, and the yield of the obtained chlorobutyl nitrile intermediate reaches 85%. 5.根据权利要求1所述的以(R)-(-)-氯代甘油为手性起始原料合成L-肉碱的制备方法,其特征在于,所述步骤(3)中,所述重结晶溶剂为水、甲醇、乙醇、乙腈或四氢呋喃,所述制得的氰盐中间体收率为80%。5. take (R)-(-)-chloroglycerol according to claim 1 as the preparation method of chiral starting material synthetic L-carnitine, it is characterized in that, in described step (3), described The recrystallization solvent is water, methanol, ethanol, acetonitrile or tetrahydrofuran, and the yield of the prepared cyanide salt intermediate is 80%. 6.根据权利要求5所述的以(R)-(-)-氯代甘油为手性起始原料合成L-肉碱的制备方法,其特征在于,所述步骤(3)中,所述重结晶溶剂为甲醇或水。6. take (R)-(-)-chloroglycerol according to claim 5 as the preparation method of chiral starting material synthetic L-carnitine, it is characterized in that, in described step (3), described The recrystallization solvent is methanol or water. 7.根据权利要求1所述的以(R)-(-)-氯代甘油为手性起始原料合成L-肉碱的制备方法,其特征在于,所述步骤(4)中,氰盐中间体水解所用酸为盐酸或硫酸溶剂。7. take (R)-(-)-chloroglycerin according to claim 1 as the preparation method of chiral starting material synthetic L-carnitine, it is characterized in that, in described step (4), cyanide salt The acid used for the hydrolysis of the intermediate is hydrochloric acid or sulfuric acid solvent.
CN 201010177701 2010-05-20 2010-05-20 Preparation method by adopting (R)-(-)-glycerinchlorohydrin as chirality starting material to synthetize L-carnitine Pending CN101823974A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201010177701 CN101823974A (en) 2010-05-20 2010-05-20 Preparation method by adopting (R)-(-)-glycerinchlorohydrin as chirality starting material to synthetize L-carnitine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201010177701 CN101823974A (en) 2010-05-20 2010-05-20 Preparation method by adopting (R)-(-)-glycerinchlorohydrin as chirality starting material to synthetize L-carnitine

Publications (1)

Publication Number Publication Date
CN101823974A true CN101823974A (en) 2010-09-08

Family

ID=42688166

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201010177701 Pending CN101823974A (en) 2010-05-20 2010-05-20 Preparation method by adopting (R)-(-)-glycerinchlorohydrin as chirality starting material to synthetize L-carnitine

Country Status (1)

Country Link
CN (1) CN101823974A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102020575A (en) * 2010-12-09 2011-04-20 浙江工业大学 Synthesis method of L-carnitine
CN103910645A (en) * 2013-01-07 2014-07-09 长春海悦药业有限公司 Levocarnitine compound and preparation method thereof
CN106957238A (en) * 2017-04-19 2017-07-18 黄冈华阳药业有限公司 A kind of preparation technology of carnitine
CN110372525A (en) * 2019-07-25 2019-10-25 抚顺顺能化工有限公司 One kind synthesizing the preparation method of l-carnitine using R- (-)-epoxychloropropane as starting material
CN113880723A (en) * 2021-11-15 2022-01-04 河南海尔希生物科技有限公司 Preparation method of betaine hydrochloride
CN115477594A (en) * 2022-10-19 2022-12-16 山东阳谷华泰化工股份有限公司 Continuous preparation method of L-canacyanol

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0060595A2 (en) * 1981-03-18 1982-09-22 ANIC S.p.A. Method for preparing L-carnitine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0060595A2 (en) * 1981-03-18 1982-09-22 ANIC S.p.A. Method for preparing L-carnitine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
《合成化学》 19981231 赵军 (3S)-beta-羟基丁酸的合成 第443页反应路线图、实验部分 1-7 第6卷, 第4期 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102020575A (en) * 2010-12-09 2011-04-20 浙江工业大学 Synthesis method of L-carnitine
CN103910645A (en) * 2013-01-07 2014-07-09 长春海悦药业有限公司 Levocarnitine compound and preparation method thereof
CN103910645B (en) * 2013-01-07 2015-07-22 长春海悦药业有限公司 Levocarnitine compound and preparation method thereof
CN106957238A (en) * 2017-04-19 2017-07-18 黄冈华阳药业有限公司 A kind of preparation technology of carnitine
CN110372525A (en) * 2019-07-25 2019-10-25 抚顺顺能化工有限公司 One kind synthesizing the preparation method of l-carnitine using R- (-)-epoxychloropropane as starting material
CN113880723A (en) * 2021-11-15 2022-01-04 河南海尔希生物科技有限公司 Preparation method of betaine hydrochloride
CN115477594A (en) * 2022-10-19 2022-12-16 山东阳谷华泰化工股份有限公司 Continuous preparation method of L-canacyanol

Similar Documents

Publication Publication Date Title
CN101823974A (en) Preparation method by adopting (R)-(-)-glycerinchlorohydrin as chirality starting material to synthetize L-carnitine
CN109400556B (en) Synthesis method of D- (-) -pantoic acid lactone
CN107311875A (en) The synthetic method of aramine
CN108912004A (en) A kind of synthetic method of pregabalin intermediate
CN101531654A (en) Preparation method for Rupatadine
CN101838212B (en) Method for synthesizing L-carnitine by using (R)-(-)-3-chlorine-1,2-propylene glycol as chiral initiative raw material
CN104130146B (en) (4S) preparation method of-3,6,9-tri-azepine-3,6,9-tri-(carboxymethyl)-4-(4-ethoxy benzyl) undecane diacids
CN101967075A (en) Method for synthesizing terminal alkyne compound by using 3-aryl-2,3-dibromopropionic acid
BR112015031722B1 (en) Method of preparation of 4-benzyl-1-phenethyl-piperazine-2,6-dione, and intermediate and method of preparation thereof
CN105481624B (en) The catalysis oxidation synthetic method of Arneel SD
CN103351346A (en) Preparation method of impurity HP1 in bendamustine hydrochloride
CN107151246A (en) A kind of preparation method of (R)-praziquantel amine salt and levo-praziquantel
CN113896645A (en) A kind of clean production method of L-p-hydroxyphenylglycine
CN1262535C (en) Method ofr synthesizing S-(1)-2.2 dimethylcyclopropane formamide
WO2021259051A1 (en) Method for improving synthesis process of hypidone free base
CN107382875A (en) A kind of synthetic method of rosuvastain calcium chiral isomer impurity
CN106631911A (en) Method for synthesizing cis-tritosylate
CN108358803B (en) Deuterated glycine, hippuric acid-L-menthyl ester (2, 2-D)2) And a process for the synthesis of intermediates thereof
CN1160358C (en) (8S, 18S)-1,4,10,13,16-pentaazatricyclo[16.3.0.04,8]hexacane-9,17-dione and its preparation method and use
CN105330585A (en) Novel mitiglinide calcium preparing method
CN103102280A (en) Preparation method of optical pure 1-(alpha-amino benzyl)-2-naphthol
CN103274956B (en) Preparation method of D-serine
CN102659657A (en) Method for synthesizing protease inhibitor PF429242
CN103724253B (en) A kind of preparation method of Mitiglinide Calcium
Yang et al. Practical and efficient utilisation of (R)-3-chloro-1, 2-propanediol in synthesis of L-carnitine

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20100908